Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Inventory Average (2016 - 2025)

Historic Inventory Average for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $16.6 million.

  • Niagen Bioscience's Inventory Average rose 5051.92% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year increase of 5051.92%. This contributed to the annual value of $11.9 million for FY2024, which is 1878.3% down from last year.
  • Latest data reveals that Niagen Bioscience reported Inventory Average of $16.6 million as of Q3 2025, which was up 5051.92% from $12.8 million recorded in Q2 2025.
  • Niagen Bioscience's 5-year Inventory Average high stood at $16.6 million for Q3 2025, and its period low was $9.9 million during Q4 2024.
  • In the last 5 years, Niagen Bioscience's Inventory Average had a median value of $13.1 million in 2021 and averaged $13.1 million.
  • As far as peak fluctuations go, Niagen Bioscience's Inventory Average plummeted by 2730.49% in 2024, and later soared by 5051.92% in 2025.
  • Niagen Bioscience's Inventory Average (Quarter) stood at $13.1 million in 2021, then increased by 15.36% to $15.2 million in 2022, then fell by 10.44% to $13.6 million in 2023, then dropped by 27.3% to $9.9 million in 2024, then soared by 68.21% to $16.6 million in 2025.
  • Its Inventory Average stands at $16.6 million for Q3 2025, versus $12.8 million for Q2 2025 and $10.2 million for Q1 2025.